Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-22-000017
Filing Date
2022-02-10
Accepted
2022-02-10 13:38:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 itci1222.txt SC 13G/A 2477
  Complete submission text file 0000814133-22-000017.txt   4054
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87380 | Film No.: 22612893
SIC: 2834 Pharmaceutical Preparations